| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Division of Molecular Carcinogenesis, Department of Hematology/Oncology [B. H., A. v. W., A. R., R. d. J., J. G., N. H.], and Department of Pathology [V. K., P. K. P., I. G-G.], Childrens Hospital Los Angeles Research Institute and the Keck School of Medicine of the University of Southern California, Los Angeles, California 90027
The adapter protein Crkl has been implicated in the abnormal signal transduction pathways activated by the Bcr/Abl oncoprotein, which causes Philadelphia-positive leukemias in humans. To investigate the role of Crkl in tumorigenesis, we have generated transgenic mice that express human Crkl from the CRKL promoter. Western blot analysis showed a 4–6-fold overexpression of transgenic Crkl above endogenous crkl in two lines and increased constitutive complex formation between Crkl and C3G, an exchange factor for the small GTPase Rap1. This was associated with a significant increase in integrin-based motility of transgenic macrophages. Overexpression of Crkl was associated with increased incidence of tumor formation, and Rap1 was activated in a metastatic mammary carcinoma. The coexpression of Crkl and Bcr/Abl in mice transgenic for P190 BCR/ABL and CRKL markedly increased the rapidity of development of leukemia/lymphoma, decreasing the average survival by 3.8 months. These results provide direct evidence that Crkl plays a role in tumor development and is important in the leukemogenesis caused by Bcr/Abl.
This article has been cited by other articles:
|
|
 |
|
  Y. Li, N. Clough, X. Sun, W. Yu, B. L. Abbott, C. J. Hogan, and Z. Dai Bcr-Abl induces abnormal cytoskeleton remodeling, beta1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathway J. Cell Sci., April 15, 2007; 120(8): 1436 - 1446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. J. Cho, J. M. Cunnick, S.-J. Yi, V. Kaartinen, J. Groffen, and N. Heisterkamp Abr and Bcr, Two Homologous Rac GTPase-Activating Proteins, Control Multiple Cellular Functions of Murine Macrophages Mol. Cell. Biol., February 1, 2007; 27(3): 899 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Dearth, X. Cui, H.-J. Kim, I. Kuiatse, N. A. Lawrence, X. Zhang, J. Divisova, O. L. Britton, S. Mohsin, D. C. Allred, et al. Mammary Tumorigenesis and Metastasis Caused by Overexpression of Insulin Receptor Substrate 1 (IRS-1) or IRS-2 Mol. Cell. Biol., December 15, 2006; 26(24): 9302 - 9314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. S. Stork and T. J. Dillon Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions Blood, November 1, 2005; 106(9): 2952 - 2961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Cho, B. Zhang, V. Kaartinen, L. Haataja, I. de Curtis, J. Groffen, and N. Heisterkamp Generation of rac3 Null Mutant Mice: Role of Rac3 in Bcr/Abl-Caused Lymphoblastic Leukemia Mol. Cell. Biol., July 1, 2005; 25(13): 5777 - 5785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Rodrigues, K. E. Fathers, G. Chan, D. Zuo, F. Halwani, S. Meterissian, and M. Park CrkI and CrkII Function as Key Signaling Integrators for Migration and Invasion of Cancer Cells Mol. Cancer Res., April 1, 2005; 3(4): 183 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Kharas and D. A. Fruman ABL Oncogenes and Phosphoinositide 3-Kinase: Mechanism of Activation and Downstream Effectors Cancer Res., March 15, 2005; 65(6): 2047 - 2053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Dai, M. Rahmani, X.-Y. Pei, P. Dent, and S. Grant Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms Blood, July 15, 2004; 104(2): 509 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lamorte, S. Rodrigues, V. Sangwan, C. E. Turner, and M. Park Crk Associates with a Multimolecular Paxillin/GIT2/{beta}-PIX Complex and Promotes Rac-dependent Relocalization of Paxillin to Focal Contacts Mol. Biol. Cell, July 1, 2003; 14(7): 2818 - 2831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Li, D. L. Guris, M. Okura, and A. Imamoto Translocation of CrkL to Focal Adhesions Mediates Integrin-Induced Migration Downstream of Src Family Kinases Mol. Cell. Biol., April 15, 2003; 23(8): 2883 - 2892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Houghton, P. C. Adamson, S. Blaney, H. A. Fine, R. Gorlick, M. Haber, L. Helman, S. Hirschfeld, M. G. Hollingshead, M. A. Israel, et al. Testing of New Agents in Childhood Cancer Preclinical Models: Meeting Summary Clin. Cancer Res., December 1, 2002; 8(12): 3646 - 3657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nishihara, M. Maeda, A. Oda, M. Tsuda, H. Sawa, K. Nagashima, and S. Tanaka DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines Blood, December 1, 2002; 100(12): 3968 - 3974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lamorte, I. Royal, M. Naujokas, and M. Park Crk Adapter Proteins Promote an Epithelial-Mesenchymal-like Transition and Are Required for HGF-mediated Cell Spreading and Breakdown of Epithelial Adherens Junctions Mol. Biol. Cell, May 1, 2002; 13(5): 1449 - 1461. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
